Dyax Corp (NASDAQ:DYAX)
During the Trading Day
| 2.53 |  +0.01 / +0.40% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 2.53 |  0.00 / 0.00% |
Volume: 10.7K |
Latest DYAX News | Press Releases
No recent news for Dyax Corp.
Today’s Trading
| Previous close | 2.52 |
| Today’s open | 2.53 |
| Day’s range | 2.48 - 2.58 |
| Volume | 439,316 |
| Average volume (3 months) | 684,167 |
| Market cap | $275.1M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +14.29% |
| Earnings growth (this year) | +9.17% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +12.13% |
| P/E ratio | NM |
| Price/Sales | 6.30 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMRIAlbany Molecular Res... | +0.06 | +0.55% |
| NVIVInvivo Therapeutics ... | 0.00 | 0.00% |
| ACTCAdvanced Cell Techno... | +0.00 | +0.14% |
| SLNCFSilence Therapeutics... | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $54.7M |
| Annual profit (last year) | -$29.3M |
| Net profit margin | -53.55% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman Henry E. Blair |
President, Chief Executive Officer & Director Gustav A. Christensen, MBA |
Corporate headquarters Burlington, Massachusetts |
Forecasts
